Synthesis antimicrobial and anticancer activity of N′- arylmethylidene-piperazine-1-carbothiohydrazide

Medicinal Chemistry Research

Volumn 22, Issue 6, 2013, Pages 2802-2808

  Kulandaivelu, Umasankar ^a   Shireesha, Boyapati ^a   Mahesh, Chidara ^a   Vidyasagar, Jannu Vincent ^a   Rao, Tadikonda Rama ^b   Jayaveera, K N ^c   Saiko, Philipp ^d   Graser, Geraldine ^d   Szekeres, Thomas ^d   Jayaprakash, Venkatesan ^e,f  

^a Vaagdevi College of Pharmacy Ramnagar   (India)

^b KLR Pharmacy College   (India)

^c JNTUA COLLEGE OF ENGINEERING   (India)

^d UNIVERSITY OF VIENNA   (Austria)

^e BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^f Regus Citi Centre   (India)

Author keywords

Antibacterial; Anticancer; Antifungal; Piperazine; Thiosemicarbazones

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CIPROFLOXACIN; N' (1 PHENYLETHYLIDENE)PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' (PHENYLMETHYLIDENE)PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' [(4 CHLOROPHENYL)METHYLIDENE]PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' [(4 HYDROXYPHENYL)METHYLIDENE]PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' [(4 METHOXYPHENYL)METHYLIDENE]PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' [(4 METHYLPHENYL)METHYLIDENE]PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' [1 (3 NITROPHENYL)ETHYLIDENE]PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' [1 (4 CHLOROPHENYL)ETHYLIDENE]PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' [1 (4 HYDROXYPHENYL)ETHYLIDENE]PIPERAZINE 1 CARBOTHIOHYDRAZIDE; N' ARYLMETHYLIDENE PIPERAZINE 1 CARBOTHIOHYDRAZIDE; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; DRUG POTENCY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC 50; KLEBSIELLA PNEUMONIAE; NONHUMAN; STAPHYLOCOCCUS AUREUS; VIBRIO CHOLERAE;

EID: 84879688615     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0279-4     Document Type: Article

References (14)

1. Alvero AB, Chen W, Sartorelli AC, Schwartz P, Rutherford T, Mor G (2006) Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) induces apoptosis in ovarian cancer cells. J Soc Gynecol Investig 13(2):145-152. doi: 10.1016/j.jsgi.2005.11.004
2. Barry A (1986) Procedure for testing antimicrobial agents in agar media: theoretical considerations. Antibiotics in laboratory Medicine Edition 2:1-26
3. Boyd MR, Paull KD (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 34(2):91-109
4. Chetan B, Bunha M, Jagrat M, Sinha BN, Saiko P, Graser G, Szekeres T, Raman G, Rajendran P, Moorthy D, Basu A, Jayaprakash V (2010) Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity. Bioorg Med Chem Lett 20(13):3906-3910. doi: 10.1016/j.bmcl.2010.05.020
5. Finch RA, Liu MC, Cory AH, Cory JG, Sartorelli AC (1999) Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity. Adv Enzyme Regul 39:3-12
6. Finch RA, Liu M, Grill SP, Rose WC, Loomis R, Vasquez KM, Cheng Y, Sartorelli AC (2000) Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): a potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. Biochem Pharmacol 59(8):983-991
7. Grever MR, Schepartz S, Chabner B The National Cancer Institute: cancer drug discovery and development program. In, 1992. vol 6. p 622
8. Klayman DL, Bartosevich JF, Griffin TS, Mason CJ, Scovill JP (1979) 2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. J Med Chem 22(7):855-862
9. Krishnan K, Prathiba K, Jayaprakash V, Basu A, Mishra N, Zhou B, Hu S, Yen Y (2008) Synthesis and ribonucleotide reductase inhibitory activity of thiosemicarbazones. Bioorg Med Chem Lett 18(23):6248-6250
10. Kulandaivelu U, Padmini VG, Suneetha K, Shireesha B, Vidyasagar JV, Rao TR, K N J, Basu A, Jayaprakash J (2011) Synthesis, antimicrobial and anticancer activity of new thiosemicarbazone derivatives. Arch Pharm (Weinheim) 344(2):84-90
11. Liu MC, Lin TS, Sartorelli AC (1995) 1 chemical and biological properties of cytotoxic α-N-Heterocyclic carboxaldehyde thiosemicarbazones. Prog Med Chem 32:1-35
12. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83(11):757-766
13. Rollas S, Küçükgüzel SG (2007) Biological activities of hydrazone derivatives. Molecules 12(8):1910-1939
14. Surveillance WHODoCD (1999) Containing antimicrobial resistance: review of the literature and report of a WHO Workshop on the Development of a Global Strategy for the Containment of Antimicrobial Resistance; Geneva, Switzerland, 4-5 February 1999. World Health Organization, Dept. of Communicable Disease Surveillance and Response, Geneva